Loading insider details...
Beta
Latest Form 4 (Sep 15, 2026): Exercise/Conversion of 18,333 MIRM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 18,333 | n/a |
| Aug 12, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale | 6,001 | $599.5K |
| Jul 8, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale | 3,124 | $380.1K |
| Jun 12, 2026 | CERUS CORP (CERS) | Sale | 20,454 | $53.2K |
| Jun 11, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Grant/Award | 21,000 | n/a |
| Jun 10, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale | 2,258 | $209.6K |
| Jun 2, 2026 | CERUS CORP (CERS) | Grant/Award | 60,000 | n/a |
| May 14, 2026 | Surrozen, Inc./DE (SRZN) | Grant/Award | 5,550 | n/a |
| Mar 17, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 13,334 | n/a |
| Jan 30, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/Award | 18,140 | n/a |